TumCP Cancer Research Results
TumCP, Tumor Cell proliferation: Click to Expand ⟱
| Source: |
| Type: |
Tumor cell proliferation is a key characteristic of cancer. It refers to the rapid and uncontrolled growth of cells that can lead to the formation of tumors.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
CCA, |
KKU-100 |
|
|
|
- |
in-vitro, |
CCA, |
KKU-213 |
|
|
|
- |
in-vitro, |
CCA, |
KKU-214 |
|
|
|
- |
in-vitro, |
CCA, |
KKU-156 |
|
|
|
- |
in-vitro, |
0-Reserved, |
KKU-452 |
|
|
|
TumCP?, LCA suppressed proliferation and induced cell death in CCA cells including KKU-100, KKU-213, KKU-214, KKU-156, and KKU-452.
TumCD?,
ROS↑, The CCAs cells were suppressed in association with LCA-induced accumulation of intracellular reactive oxygen species (ROS).
NRF2↓, Increased formation of ROS was causally related with suppression of Nrf2 and its down-stream antioxidant and cytoprotective enzymes.
BAX↑, may lead to the expression of Bax and release of cytochrome c and ensuring cell death.
Cyt‑c↑,
TumCMig↓, Interestingly, LCA could also inhibit cell migration and cell cycle arrest at low concentrations.
TumCCA↑,
NF-kB↓, These effects were associated with down-regulation of NF-kB, STAT3 and their down-stream proteins, cyclin D1, VEGF, and ICAM-1.
STAT3↓,
cycD1/CCND1↓,
VEGF↓,
ICAM-1↓,
Bcl-xL↓, LG-EO and citral prevented Src-TK from phosphorylating Stat3(Y705), resulting in decreased Bcl-xL and Mcl-1 expression, in turn suppressing the proliferation/survival of SCLC cells.
Mcl-1↓,
TumCP↓,
STAT3↑, The results of the present study demonstrated that LG-EO and its major constituent, citral, inhibited the constitutive activation of Src-TK, resulting in suppression of Stat3 activity
TumCP?, decline of proliferation/survival in all four of the SCLC cell lines examined.
Showing Research Papers: 1 to 2 of 2
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
NRF2↓, 1, ROS↑, 1,
Cell Death(tgid=5) ⓘ
BAX↑, 1, Bcl-xL↓, 1, Cyt‑c↑, 1, Mcl-1↓, 1, TumCD?, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
cycD1/CCND1↓, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
STAT3↓, 1, STAT3↑, 1,
Migration(tgid=13) ⓘ
TumCMig↓, 1, TumCP?, 2, TumCP↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
VEGF↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
ICAM-1↓, 1, NF-kB↓, 1,
Total Targets: 17
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: TumCP, Tumor Cell proliferation
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:327 State#:% Dir#:0
wNotes=on sortOrder:rid,rpid
Home Page